Lipid composition heatmap for Study ST004022

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Treatment:57E (20 microM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5
Treatment:57E (20 microM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5
Treatment:57E (40 microM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5
Treatment:L-Alanine (20 mM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5
Treatment:L-Alanine (20 mM) | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5
Treatment:vehicle | Doxycycline (y/n):no | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5
Treatment:vehicle | Doxycycline (y/n):no | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5
Treatment:vehicle | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):0.1 | MeAIB concentration (mM):0.5
Treatment:vehicle | Doxycycline (y/n):yes | Sample source:HY15549 Pancreatic Cancer Cells | Final DMSO (%):5 | MeAIB concentration (mM):0.5
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

no data for these lipids in this study